Latest market price
6.15
-0.14-2.23%
OverviewShort InterestFilings
RGCQT13Regencell Bioscience Holdings Limited·NASDAQ
6.15-2.23%

Latest SEC Filings

Form category
DescriptionFilingDocument
Oct 07, 202620-FAnnual report (foreign issuers)
May 29, 20264Statement of changes in beneficial ownership
May 29, 20264Statement of changes in beneficial ownership
May 22, 20266-KForeign issuer report
May 19, 2026424B5Prospectus
May 19, 20266-KForeign issuer report
May 19, 20266-KForeign issuer report
May 08, 20266-KForeign issuer report
Apr 17, 20266-KForeign issuer report
Mar 30, 2026424B5Prospectus
Mar 30, 20266-KForeign issuer report
Mar 30, 2026F-3ASRF-3ASR
Mar 30, 20266-KForeign issuer report
Mar 18, 20263Initial statement of beneficial ownership
Mar 18, 20263Initial statement of beneficial ownership
Mar 18, 20263Initial statement of beneficial ownership
Mar 18, 20263Initial statement of beneficial ownership
Mar 18, 20263Initial statement of beneficial ownership
Mar 18, 20263Initial statement of beneficial ownership
Mar 18, 20263Initial statement of beneficial ownership
Feb 13, 20266-KForeign issuer report
Oct 31, 202520-FAnnual report (foreign issuers)
Jul 11, 2025SC 13D/ABeneficial ownership statement (active, amended)
Jun 30, 20256-KForeign issuer report
Jun 30, 20256-KForeign issuer report
#1 / 25 of 72
Page
▼
/ 3